New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists.

[1]  T. Choueiri,et al.  Adenosine A2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer. , 2019, Cancer discovery.

[2]  G. Marucci,et al.  Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain. , 2019, Journal of medicinal chemistry.

[3]  K. Varani,et al.  Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity. , 2019, Journal of medicinal chemistry.

[4]  Min Zhang,et al.  Inactivation of endothelial adenosine A2A receptors protects mice from cerebral ischaemia‐induced brain injury , 2019, British journal of pharmacology.

[5]  G. Marucci,et al.  Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells. , 2019, Bioorganic chemistry.

[6]  G. Marucci,et al.  Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity. , 2019, Bioorganic & medicinal chemistry letters.

[7]  K. Varani,et al.  Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2A adenosine receptor. , 2018, European journal of medicinal chemistry.

[8]  K. Varani,et al.  Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1 and A2A adenosine receptor antagonists/inverse agonists. , 2018, Bioorganic & medicinal chemistry.

[9]  Pier Andrea Borea,et al.  Pharmacology of Adenosine Receptors: The State of the Art. , 2018, Physiological reviews.

[10]  K. Varani,et al.  The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor. , 2018, European journal of medicinal chemistry.

[11]  K. Varani,et al.  Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 , 2017, Front. Pharmacol..

[12]  M. Liang,et al.  Serial millisecond crystallography for routine room-temperature structure determination at synchrotrons , 2017, Nature Communications.

[13]  A. Cavalli,et al.  The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype. , 2017, Journal of medicinal chemistry.

[14]  F. Cayabyab,et al.  Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration , 2017, Molecules.

[15]  M. Sturlese,et al.  The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles , 2017, Journal of enzyme inhibition and medicinal chemistry.

[16]  K. Varani,et al.  Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity. , 2016, Journal of medicinal chemistry.

[17]  P. Darcy,et al.  Immunosuppressive activities of adenosine in cancer. , 2016, Current opinion in pharmacology.

[18]  K. Varani,et al.  Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? , 2016, Trends in pharmacological sciences.

[19]  A. Abdel‐Rahman,et al.  Role of adenosine A2A receptor in cerebral ischemia reperfusion injury: Signaling to phosphorylated extracellular signal-regulated protein kinase (pERK1/2) , 2016, Neuroscience.

[20]  F. Pedata,et al.  Adenosine A2A Receptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia , 2014, Mediators of inflammation.

[21]  R. Cunha,et al.  Role of Microglia Adenosine A2A Receptors in Retinal and Brain Neurodegenerative Diseases , 2014, Mediators of inflammation.

[22]  L. Antonioli,et al.  Immunity, inflammation and cancer: a leading role for adenosine , 2013, Nature Reviews Cancer.

[23]  M. Smyth,et al.  Extracellular adenosine triphosphate and adenosine in cancer , 2010, Oncogene.

[24]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.